Literature DB >> 30617216

Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections.

Dana T Lounder1, Qiong Bin2,3, Cristina de Min4, Michael B Jordan2,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30617216      PMCID： PMC6325304          DOI： 10.1182/bloodadvances.2018025858

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  17 in total

Review 1.  CXCR3 ligands: redundant, collaborative and antagonistic functions.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2011-01-11       Impact factor: 5.126

2.  Neutralization of IFN-γ reverts clinical and laboratory features in a mouse model of macrophage activation syndrome.

Authors:  Giusi Prencipe; Ivan Caiello; Antonia Pascarella; Alexei A Grom; Claudia Bracaglia; Laurence Chatel; Walter G Ferlin; Emiliano Marasco; Raffaele Strippoli; Cristina de Min; Fabrizio De Benedetti
Journal:  J Allergy Clin Immunol       Date:  2017-08-12       Impact factor: 10.793

3.  Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.

Authors:  Elisabet Bergsten; AnnaCarin Horne; Maurizio Aricó; Itziar Astigarraga; R Maarten Egeler; Alexandra H Filipovich; Eiichi Ishii; Gritta Janka; Stephan Ladisch; Kai Lehmberg; Kenneth L McClain; Milen Minkov; Scott Montgomery; Vasanta Nanduri; Diego Rosso; Jan-Inge Henter
Journal:  Blood       Date:  2017-09-21       Impact factor: 22.113

4.  Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children.

Authors:  Xiao-Jun Xu; Yong-Min Tang; Hua Song; Shi-Long Yang; Wei-Qun Xu; Ning Zhao; Shu-Wen Shi; He-Ping Shen; Jun-Qing Mao; Ling-Yan Zhang; Bin-Hua Pan
Journal:  J Pediatr       Date:  2012-01-09       Impact factor: 4.406

Review 5.  Salvage therapy for refractory hemophagocytic lymphohistiocytosis: A review of the published experience.

Authors:  Rebecca A Marsh; Michael B Jordan; Julie-An Talano; Kim E Nichols; Ashish Kumar; Ahmed Naqvi; Sarah R Vaiselbuh
Journal:  Pediatr Blood Cancer       Date:  2016-10-27       Impact factor: 3.167

6.  Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.

Authors:  Karen Put; Anneleen Avau; Ellen Brisse; Tania Mitera; Stéphanie Put; Paul Proost; Brigitte Bader-Meunier; René Westhovens; Benoit J Van den Eynde; Ciriana Orabona; Francesca Fallarino; Lien De Somer; Thomas Tousseyn; Pierre Quartier; Carine Wouters; Patrick Matthys
Journal:  Rheumatology (Oxford)       Date:  2015-03-12       Impact factor: 7.580

Review 7.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.

Authors:  Xiaoyu Hu; Lionel B Ivashkiv
Journal:  Immunity       Date:  2009-10-16       Impact factor: 31.745

8.  Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Authors:  Claudia Bracaglia; Kathy de Graaf; Denise Pires Marafon; Florence Guilhot; Walter Ferlin; Giusi Prencipe; Ivan Caiello; Sergio Davì; Grant Schulert; Angelo Ravelli; Alexei A Grom; Cristina de Min; Fabrizio De Benedetti
Journal:  Ann Rheum Dis       Date:  2016-06-13       Impact factor: 19.103

Review 9.  PD-1 and PD-1 ligands: from discovery to clinical application.

Authors:  Taku Okazaki; Tasuku Honjo
Journal:  Int Immunol       Date:  2007-07-02       Impact factor: 4.823

10.  Use of a mouse model to identify a blood biomarker for IFNγ activity in pediatric secondary hemophagocytic lymphohistiocytosis.

Authors:  Vanessa Buatois; Laurence Chatel; Laura Cons; Sabrina Lory; Françoise Richard; Florence Guilhot; Zoë Johnson; Claudia Bracaglia; Fabrizio De Benedetti; Cristina de Min; Marie H Kosco-Vilbois; Walter G Ferlin
Journal:  Transl Res       Date:  2016-08-04       Impact factor: 7.012
View more
  36 in total

1.  Line-selective macrophage activation with an anti-CD40 antibody drives a hemophagocytic syndrome in mice.

Authors:  Giada Ingoglia; Ayla Yalamanoglu; Marc Pfefferlé; Irina L Dubach; Christian A Schaer; Kristyna Valkova; Kerstin Hansen; Nadja Schulthess; Rok Humar; Dominik J Schaer; Florence Vallelian
Journal:  Blood Adv       Date:  2020-06-23

Review 2.  Pediatric hemophagocytic lymphohistiocytosis.

Authors:  Scott W Canna; Rebecca A Marsh
Journal:  Blood       Date:  2020-04-16       Impact factor: 22.113

3.  Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis.

Authors:  Matthias Felber; Colin G Steward; Karim Kentouche; Anders Fasth; Robert F Wynn; Ulrike Zeilhofer; Veronika Haunerdinger; Benjamin Volkmer; Seraina Prader; Bernd Gruhn; Stephan Ehl; Kai Lehmberg; Daniel Müller; Andrew R Gennery; Michael H Albert; Fabian Hauck; Kanchan Rao; Paul Veys; Moustapha Hassan; Arjan C Lankester; Jana Pachlopnik Schmid; Mathias M Hauri-Hohl; Tayfun Güngör
Journal:  Blood Adv       Date:  2020-05-12

Review 4.  Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg.

Authors:  Courtney Crayne; Randy Q Cron
Journal:  Eur J Rheumatol       Date:  2019-12-03

Review 5.  Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management.

Authors:  Lauren A Henderson; Randy Q Cron
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

6.  Interleukin-18 and cytotoxic impairment are independent and synergistic causes of murine virus-induced hyperinflammation.

Authors:  Paul Tsoukas; Emily Rapp; Lauren Van Der Kraak; Eric S Weiss; Vinh Dang; Corinne Schneider; Edwin Klein; Jennifer Picarsic; Rosalba Salcedo; C Andrew Stewart; Scott W Canna
Journal:  Blood       Date:  2020-11-05       Impact factor: 22.113

7.  Inflammation Unrestrained by SIRPα Induces Secondary Hemophagocytic Lymphohistiocytosis Independent of IFN-γ.

Authors:  Koby Kidder; Zhen Bian; Lei Shi; Yuan Liu
Journal:  J Immunol       Date:  2020-10-07       Impact factor: 5.422

Review 8.  Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation.

Authors:  Isabelle Amigues; Alexander H Pearlman; Aarat Patel; Pankti Reid; Philip C Robinson; Rashmi Sinha; Alfred Hj Kim; Taryn Youngstein; Arundathi Jayatilleke; Maximilian Konig
Journal:  Expert Rev Clin Immunol       Date:  2020-11-25       Impact factor: 4.473

9.  Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.

Authors:  Adriana A de Jesus; Yangfeng Hou; Stephen Brooks; Louise Malle; Angelique Biancotto; Yan Huang; Katherine R Calvo; Bernadette Marrero; Susan Moir; Andrew J Oler; Zuoming Deng; Gina A Montealegre Sanchez; Amina Ahmed; Eric Allenspach; Bita Arabshahi; Edward Behrens; Susanne Benseler; Liliana Bezrodnik; Sharon Bout-Tabaku; AnneMarie C Brescia; Diane Brown; Jon M Burnham; Maria Soledad Caldirola; Ruy Carrasco; Alice Y Chan; Rolando Cimaz; Paul Dancey; Jason Dare; Marietta DeGuzman; Victoria Dimitriades; Ian Ferguson; Polly Ferguson; Laura Finn; Marco Gattorno; Alexei A Grom; Eric P Hanson; Philip J Hashkes; Christian M Hedrich; Ronit Herzog; Gerd Horneff; Rita Jerath; Elizabeth Kessler; Hanna Kim; Daniel J Kingsbury; Ronald M Laxer; Pui Y Lee; Min Ae Lee-Kirsch; Laura Lewandowski; Suzanne Li; Vibke Lilleby; Vafa Mammadova; Lakshmi N Moorthy; Gulnara Nasrullayeva; Kathleen M O'Neil; Karen Onel; Seza Ozen; Nancy Pan; Pascal Pillet; Daniela Gp Piotto; Marilynn G Punaro; Andreas Reiff; Adam Reinhardt; Lisa G Rider; Rafael Rivas-Chacon; Tova Ronis; Angela Rösen-Wolff; Johannes Roth; Natasha Mckerran Ruth; Marite Rygg; Heinrike Schmeling; Grant Schulert; Christiaan Scott; Gisella Seminario; Andrew Shulman; Vidya Sivaraman; Mary Beth Son; Yuriy Stepanovskiy; Elizabeth Stringer; Sara Taber; Maria Teresa Terreri; Cynthia Tifft; Troy Torgerson; Laura Tosi; Annet Van Royen-Kerkhof; Theresa Wampler Muskardin; Scott W Canna; Raphaela Goldbach-Mansky
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 10.  Interferon target-gene expression and epigenomic signatures in health and disease.

Authors:  Franck J Barrat; Mary K Crow; Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2019-11-19       Impact factor: 25.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.